Meeting
2015 ASCO Annual Meeting
Relationship of germline polymorphisms to docetaxel toxicity in the ROSE/TRIO-012 trial.
Authors
Sambasivarao Damaraju
University of Alberta/Cross Cancer Institute, Edmonton, AB, Canada
Sambasivarao Damaraju , Vera Gorbunova , Karen A. Gelmon , Jose Angel Garcia Saenz , Serafin Morales , Dany Youssef Abigerges , Jean-Luc Canon , Igor Lifirenko , Graham Lawrence Cohen , Guy Heinrich Maria Jerusalem , Francois Thireau , Rodrigo Fresco , Vincent Houé , Michael F. Press , Ashok Narasimhan , John Robert Mackey
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer—HER2/ER
Track
Breast Cancer
Sub Track
ER+
Citation
J Clin Oncol 33, 2015 (suppl; abstr 540)
DOI
10.1200/jco.2015.33.15_suppl.540
Abstract #
540
Poster Bd #
28
Abstract Disclosures
Similar Posters
Poster
2015 ASCO Annual Meeting
Association of paclitaxel-induced sensory peripheral neuropathy with the ABCB1 genetic variant and age.
First Author: Chikako Shimizu
Poster
2015 ASCO Annual Meeting
Genetics of ramucirumab-associated hypertension in the ROSE/TRIO-012 breast cancer trial.
First Author: John Robert Mackey
Poster
2014 ASCO Annual Meeting
Paclitaxel-induced severe sensory peripheral neuropathy is associated with NDRG-1 genetic variant and negative NDRG-1 expression in nerve tissue.
First Author: Raghav Sundar
Poster
2013 ASCO Annual Meeting
A genome-wide association study (GWAS) of docetaxel-induced peripheral neuropathy in CALGB 90401 (Alliance).
First Author: Daniel Louis Hertz